Alzheimer Disease Clinical Trials in Wroclaw
3 recruitingWroclaw, Poland
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Alzheimer Disease
Karuna Therapeutics406 enrolled278 locationsNCT06585787
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 2
A Study of NTRX-07 in Participants With Alzheimer's Disease
Alzheimer DiseaseMild Cognitive Impairment
NeuroTherapia, Inc.48 enrolled6 locationsNCT07058688